Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk - Poll - MDSpire

Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk

  • By

  • Sailish Honap

  • Marc Debouverie

  • Massimo Filippi

  • Daniel Selchen

  • Vipul Jairath

  • Silvio Danese

  • Laurent Peyrin-Biroulet

  • November 29, 2025

  • 0 min

Share

Original Source(s)

Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk

  • by Sailish Honap, Marc Debouverie, Massimo Filippi, Daniel Selchen, Vipul Jairath, Silvio Danese, Laurent Peyrin-Biroulet

  • November 29, 2025

Related Content

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Association Between Delivery Method and Offspring's Risk of Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis